Overall, the tumor proliferation, measured by the immunohistochemical assessment of Ki67 antigen, a nuclear protein expressed in all cell-cycle phases other than G0, together with hormone receptor and human epidermal growth factor receptor 2 (HER2) status, stage and histological grade, represent the main accepted prognostic factors for early breast cancer [11]. Here, ERBB2 is linked to breast carcinoma.